Octave Bioscience is a biotechnology company that is developing a platform for personalized medicine. The company was founded in 2017 and is headquartered in Brisbane, California. Octave's platform combines genomics, proteomics, and machine learning to provide patients with personalized treatment options for neurological diseases such as multiple sclerosis. The company's mission is to improve patient outcomes by providing more accurate diagnoses and personalized treatment plans.